Overview
CLPT market data
Price History
CLPT price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.90 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.18 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $8.27 – $30.10 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $536.8 · P/B 14.52 · P/S 13.22.
Company news
B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $30Benzinga · Jun 18, 2026, 6:00 PM
Jabil Posts Upbeat Q3 Results, Joins Uniqure, Braiin And Other Big Stocks Moving Higher On WednesdayBenzinga · Jun 17, 2026, 2:20 PM
ClearPoint Neuro Collaborates With SONOCARELAB To Tap Focused Ultrasound MarketBenzinga · May 27, 2026, 8:40 PM
8-K filing — ClearPoint Neuro, Inc. (CLPT)SEC EDGAR · May 21, 2026, 8:30 PM
ClearPoint Neuro shares are trading higher after the company reported better-than-expected Q1 sales results and reaffirmed its FY26 sales guidance with its midpoint above estimates.Benzinga · May 14, 2026, 5:16 PM
ClearPoint Neuro Q1 2026 Earnings Call TranscriptBenzinga · May 13, 2026, 9:39 PM
ClearPoint Neuro Affirms FY2026 Sales Guidance of $52.000M-$56.000M vs $52.800M EstBenzinga · May 13, 2026, 8:07 PM
ClearPoint Neuro Q1 EPS $(0.32) Misses $(0.26) Estimate, Sales $12.128M Beat $12.000M EstimateBenzinga · May 13, 2026, 8:06 PM
ClearPoint Neuro Says Velocity Alpha MR High Speed Surgical Drill System Receives CE Marking In Addition To Existing FDA 510(k) Clearance In USBenzinga · May 13, 2026, 8:01 PM
Earnings Scheduled For May 13, 2026Benzinga · May 13, 2026, 11:11 AM